SCHEMBL7288765

SCHEMBL7288765

CCCCCOc1ccc(-c2ccc(C=O)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.63
LMNA P02545 1/20 0.63
MAPT P10636 1/20 0.63
HPGD P15428 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
RARB P10826 4/20 0.58
CYP3A4 P08684 3/20 0.54
CYP2D6 P10635 3/20 0.54
NR5A1 Q13285 1/20 0.51
LTA4H P09960 2/20 0.50
CYP19A1 P11511 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
CYP1A2 P05177 1/20 0.50
PLA2G4B P0C869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13739981 1.00 ALDH1A1 (0.63) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL3086009 0.98 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL2123631 0.98 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL3071049 0.98 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL7289971 0.98 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL3077169 0.96 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1443663 0.95 ALDH1A1 (0.69) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1164661 0.93 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1239921 0.93 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL585375 0.93 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575964-B1 N-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATES, PHOSPHONATES AND TETRAZOLES AS EDG RECEPTOR AGONISTS MERCK & CO INC (US) 2009-11-11 EP disclosed
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed
CN-1057306-C New polypeptide compound and a process for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 2000-10-11 CN disclosed
EP-0644199-B1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 2000-07-19 EP disclosed
US-5693750-A MICROBIOCIDAL ACTION AGAINST PNEUMOCYSTIS INFECTIONS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-12-02 US disclosed
US-5569646-A TREATMENT OF PNEUMONIA; MICROBIOCIDES, FUNGICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-29 US disclosed
EP-0644199-A1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-22 EP disclosed
CN-1100104-A New polypeptide compound and a process for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-03-15 CN disclosed